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PRC2 enacts Wnt signaling in intestinal homeostasis and contributes to the instigation of 
stemness in diseases entailing epithelial hyperplasia or neoplasia 
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Canonical Wnt/β-catenin signaling regulates the homeostasis of intestinal epithelium by controlling the 
balance between intestinal stem cell self-renewal and differentiation but epigenetic mechanisms 
enacting the process are not known. We hypothesized that epigenetic regulator, Polycomb Repressive 
Complex-2 (PRC2), is involved in Wnt-mediated epithelial homeostasis on the crypt-villus axis and 
aberrancies therein are implicated both in celiac disease and in intestinal malignancies. We found that 
PRC2 establishes repressive crypt and villus specific H3K27me3 signature on genes responsible for 
e.g. nutrient transport and cell killing in crypts and e.g. proliferation and differentiation in mature villi, 
suggesting that PRC2 facilitates the Wnt-governed intestinal homeostasis. When celiac patients are on 
gluten-containing diet PRC2 is out-of-bounds active and consequently its target genes were found 
affected in intestinal epithelium. Significant set of effective intestinal PRC2 targets are also 
differentially expressed in colorectal adenoma and carcinomas. Our results suggest that PRC2 gives 
rise and maintains polar crypt and villus specific H3K27me3 signatures. As H3K27me3 is a mark 
enriched in developmentally important genes, identified intestinal PRC2 targets are possibly imperative 
drivers for enterocyte differentiation and intestinal stem cell maintenance downstream to Wnt-
signaling. Our work also elucidate the mechanism sustaining the crypt hyperplasia in celiac disease and 
suggest that PRC2-dependent fostering of epithelial stemness is a common attribute in intestinal 
diseases in which epithelial hyperplasia or neoplasia prevails. Finally, this work demonstrates that in 
intestine PRC2 represses genes having both pro-stemness and pro-differentiation functions, fact need to 
be considered when designing epigenetic therapies including PRC2 as a drug target. 
 
 




Polycomb Group (PcG) proteins regulate developmental gene expression during cell differentiation. 
PcG proteins are essential for embryonic stem cell self-renewal and pluripotency but they are also 
necessary for the maintenance of cell identity and cell differentiation throughout life [1]. PcG proteins 
form at least two Polycomb Repressive Complexes (PRC). PRC2 catalyses trimethylation of histone 
H3 lysine 27 (H3K27me3), forming a binding site for PRC1 [2]. In embryonic stem cells PRC2 
represses the expression of developmental regulators necessary for cell differentiation [3]. In 
differentiated cells, genes important for the given cell identity lose H3K27me3 whereas genes that 
regulate alternate cell-types remain methylated and repressed [4]. 
Perturbations in epigenetic mechanisms can contribute to diseases such as cancer. For 
instance, PcG protein EZH2 has been shown to be overexpressed in endometrial, prostate, breast, 
colon, lung and skin cancers [5]. It has been shown that overexpressed PcG proteins keep cells in more 
proliferative, low differentiation state that inevitably is one of the hallmarks of cancer. The crypt-villus 
axis constitutes a functional unit of the small intestine, where intestinal stem cells (ISC) and transit 
amplifying (TA), migrating and differentiating precursor epithelial cells are restricted to the crypts and 
mature absorptive epithelial cells are restricted to the villi. Epithelial cells undergo rapid turnover, and 
thus are tightly regulated to maintain homeostasis between proliferation, differentiation and apoptosis 
[6]. Reminiscent of hyper-proliferative state in cancer, the main manifestation of dietary gluten-induced 
celiac disease, is also the increased proliferative and lesser differentiation state, namely of the 
epithelium of the small intestine showing an enteropathy with crypt hyperplasia and villous atrophy [7]. 
Wnt-signaling genes are bound by PRC2 in human embryonic stem (ES) cells [8] and 
also in adult tissues e.g. in adipogenesis [9]. Canonical Wnt-signaling is essential for homeostasis of 
the healthy intestinal epithelium [10] but epigenetic factors running the errands of Wnt-signaling in 
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intestine are not known. Recently it has been proposed that intestinal stem cells as well as secretory and 
absorptive progenitor cells show comparable levels of histone modifications at most of the same cis-
elements in the genome [11]. This work measured the levels of H3K4me2 and H3K27ac, whereas 
PRC2 activity (H3K27me3) was not investigated. Recently, it was shown that PRC1 activity is required 
for the integrity of the intestinal epithelium [12] but whether PRC2 is involved in the differentiation of 
the epithelium of the small intestine is not currently known. We pursued to understand this by using 
mouse mini-gut organoid cultures [13] and high-throughput-methods, such as ChIP-Seq and GRO-Seq 
to identify factors that contribute to the development of the small intestine. We found that PRC2 
regulates substantial subset of genes, which in particular, have a function in development of the gut 
epithelium. Furthermore, we found that aberrant PRC2 activity is associated with celiac disease, and 
the PRC2 governed intestinal transcriptome is dysregulated in colorectal adenomas and cancers. 
MATERIALS AND METHODS 
Mini-gut organoid and cell line cultures 
Mouse mini-gut organoids were grown essentially as described previously [13, 14]. To model intestinal 
crypt-villus axis organoids were grown in the presence of Wnt3A, EGF, Noggin, R-spondin and CHIR-
99021 (WENRC stem cell media) and differentiation was induced by omitting Wnt3A and CHIR-
99021 and media was supplemented with Wnt-inhibitor IWP-2 (ENRI enterocyte differentiation 
media). T84 cells were grown as previously [15] except we used Matrigel GFR instead of collagen. 
Patient material 
Altogether six stored formalin-fixed and paraffin-embedded small intestinal biopsy samples from adult 
celiac disease patients adhering to a strict gluten-free diet for at least two years and being in clinical 
remission were selected, as well as their biopsies after a 12-week gluten challenge [16]. The study 
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protocol was approved by the Ethics Committee of Tampere University Hospital, (Ethical permission 
R07129M). All subjects had given written informed consent. 
ChIP-Seq analysis 
Mini-gut organoids (in WENRC and ENRI culturing conditions) were isolated from Matrigel with Cell 
Recovery Solution (Corning, NY) followed by washes with cold PBS and brought to single cell 
suspension with TrypLE Express (Thermo Fisher Scientific, Waltham, MA) and counted. Equal 
number of cells were cross-linked with formaldehyde and nuclei were isolated, lysed, and sonicated 
with a Covaris S220 ultrasonicator. The resulting nuclear extract was incubated overnight at 4 °C with 
Dynal Protein G beads pre-incubated with 5µg of H3K27me3 or H3 (ab6002 and ab1791, respectively, 
Abcam, Cambridge, UK) antibody. Beads were washed and bound complexes eluted, and cross-links 
were reversed by heating to 65 °C. IP and input DNA were then purified by a treatment with RNAse A, 
proteinase K, and phenol:chloroform extraction. Libraries were constructed from IP and input DNA by 
NEBnext® Ultra™ DNA-library preparation kit for Illumina (NEB, Ipswich, MA) and subjected to 50 
bp single-end read sequencing with Illumina Hiseq 2000 at EMBL Genecore, Heidelberg, Germany.  
GRO-Seq analysis 
Organoids were harvested (as in ChIP-Seq) and GRO-Seq was performed for equal number of isolated 
nuclei from WENRC and ENRI conditions grown organoids. The nuclei extraction and run on reaction 
was performed as described [17]. For each replicate, 3 million cells were suspended to a final volume 
of 80-200 µl of freezing buffer. The RNA was extracted using Trizol LS (Life Technologies, Carlsbad, 
CA), fragmented 13 mins in 70°C using RNA Fragmentation Reagents (Life Technologies) and 
purified by running through RNase-free P-30 column (Bio-Rad, Hercules, CA). The RNA was 
dephosphorylated with PNK for 2 hours (New England Biolabs, Ipswich, MA) followed by heat-
Page 6 of 69
7 
 
inactivation. Dephosphorylation reactions were purified using 65 µl of blocked (5x volume of 
0.25xSSPE, 1 mM EDTA, 37.5 mM NaCl, 0.05% Tween-20, 0.1%PVP and 0.1% ultrapure BSA for 
1hour in RT) anti-BrdU bead slurry (SantaCruz Biotech, Santa Cruz, CA) suspended in 500 µl of 
binding buffer (0.25xsSSPE, 1 mM EDTA, 37.5 mM NaCl 0.05% Tween-20). After binding for 1 h in 
RT, the beads were washed twice with binding buffer, twice with low salt buffer (0.2xSSPE, 1mM 
EDTA, 0.05% Tween-20) and once with high salt buffer (0.2xSSPE, 1mM EDTA, 135 mM 
NaCl0.05% Tween-20) and twice with TE-buffer (1xTE, 0.05% Tween-20). The RNA was eluted three 
times by using 130 µl of elution buffer (50 mM Tris-HCl pH 7.5, 150 mM NaCl, 0.1% SDS, 1mM 
EDTA and 20 mM DTT) followed by ethanol precipitation overnight. All buffers were supplemented 
with SUPERase In (2 µl/10ml; Life Technologies). The library preparation was performed the next day 
as described [18]. The libraries were amplified for 14 cycles and the final product of 190-350bp was 
extracted from on 10% Novex TBE gel (Life Technologies) and eluted from crushed gel slice twice 
using 100µl of elution buffer (TE+0.1% Tween+150 mM NaCl). The libraries were purified using ChIP 
DNA clean & Concentrator Kit (Zymo Research Corporation, Irvine, CA), quantified using the Qubit 
fluorometer and sequenced using Illumina HiSeq 2000 at EMBL Genecore, Heidelberg, Germany. 
ChIP- and Gro-seq data analyses 
Analyses were performed essentially as described in [17–19] (see Supplemental materials and methods 
for detailed descriptions of data analyses) 
Immunohistochemistry  
Formalin fixed paraffin embedded duodenal biopsies were cut to tissue sections and subjected to 
immunohistochemical staining using antibodies against Suz12 (Cell Signaling D39F6, 1:1600), Scin 
(Sigma-Aldrich HPA022009, 1:50) and SPHK1 (Sigma-Aldrich HPA028761, 1:100). Standard staining 
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procedures including heat induced epitope retrieval and quenching of endogenous peroxidase activity 
prior to antibody incubation were used. Patients on gluten free diet and gluten containing diet were 
compared (n=6) by evaluating the Suz12 staining. Length of the Suz12 positive area in 2-5 correctly 
aligned crypts was counted for each sample and reported as median. 
Crude mechanical separation of mouse duodenal villi and crypts-TA fractions   
Duodenal fragments were harvested from C57BL/6 mice and washed gently with cold PBS. Villus 
epithelium was released by pipetting fiercely up and down ten times in 15ml of cold PBS with 25ml 
pipette. PBS with released villus epithelium was collected and remaining epithelia in duodenal 
fragment was collected with 10ml washes of cold PBS two times and pooled with villus fraction. 
Remaining duodenal fragments were incubated in PBS-10mM EDTA at +4°C with gentle shaking. 
PBS-EDTA solution was removed and crypt-TA fraction was released by vigorously pipetting up and 
down thirty times in cold PBS followed by two subsequent washes with cold PBS.  
Western blot for cells treated with EZH2 inhibitor 
T84 cells and mouse organoids were treated with 5 µM of EZH2 methyltransferase inhibitor[20] for six 
days and cells were lysed in laemmli buffer, heated and ran to 15% SDS-PAGE gels and transferred to  
Hybond-C membrane (Amersham Biosciences, Bucks, UK). Decrease of bulk trimethylation of H3K27 
was assessed with ab6002 antibody and compared to bulk amount of H3 ab1791 antibody (Abcam, 
Cambridge, UK) 
Quantitative reverse transcription PCR (qRT-PCR) 
RNA was extracted from cells/tissues using Trizol® (Invitrogen, CA) according to manufacturer’s 
protocol. cDNA was synthesised with iScript™ cDNA synthesis kit, quantitative PCR reactions were 
performed with SsoFast™ EvaGreen® Supermix and reactions were run in CFX96 real-time PCR 
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detection systems (Bio-Rad laboratories, CA). List of qRT-PCR oligos used in this study are shown in 
Supplemental materials and methods. 
 
RESULTS 
PRC2 members are expressed in proliferating cells in intestinal crypts and regulate enterocyte 
differentiation 
Research conducted using intestinal cancer-cell models have previously shown that disrupting PRC2 
activity leads to a significant precocious expression of a number of terminal differentiation markers 
[21]. We also tested the effect of PRC2 inhibition by pharmacologically inhibiting the methyl 
transferase activity of EZH2 [20] in T84 cell intestinal differentiation model [15]. Inhibition of PRC2 
activity significantly induced enterocyte differentiation (ALPI mRNA) with the concomitant decrease 
of the intestinal stem cell (ISC) marker LGR5 mRNA (figure 1A). Markers for paneth, enteroendocrine 
and goblet cells remained adamant, suggesting that PRC2 is governing only the enterocyte 
differentiation program in T84 cells. Next we sought to investigate whether PRC2 regulates enterocyte 
differentiation also in mouse mini-gut organoids [13, 22]. Inhibition of PRC2 activity, similarly as in 
T84 cells, induced significant and enterocyte specific differentiation with the concomitant decrease of 
ISC marker LGR5 (figure 1B).  
To facilitate the study of PRC2 function in intestinal differentiation we optimized the 
mini-gut culture conditions to best recapitulate the composition of cell population along the crypt-villus 
axis. WENRC vs. ENRI (see methods) culturing conditions were best suited for this purpose as 
markers for crypt/ISC compartment were highly enriched; (LGR5 mRNA) 100-fold and paneth cells 
(LYZ mRNA) 14-fold, when mini-guts were cultured in WENRC compared to ENRI media. 
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Reciprocally, enterocytes (ALPI mRNA), enteroendocrine cells (CHGA mRNA) and goblet cells 
(MUC2 mRNA) were 50, 3 and 9 –fold upregulated in mini-guts grown in ENRI-media, respectively 
(Supplemental figure 1A-C). By immunohistochemical staining PRC2 has been shown to be expressed 
in transit amplifying zone (TA-zone) in the crypt where commitment to enterocyte differentiation is 
also taking place [21]. In addition to yielding composition of cell populations comparable to in vivo 
crypt and villus tip, also PRC2 members, SUZ12 and EZH2 were both ~5 to 7-fold less expressed in 
mini-guts differentiated with ENRI-media (figure 1C). We found this comparable with the in vivo 
expression of PRC2 members in crypt-villus-axis when measured from villus and crypt/ISCs+TA 
fractions isolated from mouse (figure 1D). Our data suggest that PRC2 regulates enterocyte 
differentiation in vitro and is expressed in intestinal crypt/TA-region and also demonstrates that the 
function of PRC2 in enterocyte differentiation can be studied in mini-gut organoid model.     
 
PRC2 specify the crypt and villus domains in the small intestine 
We next sought to determine the role of PRC2 in the epigenetic maintenance of ISCs and how 
epigenome is reprogrammed during the enterocyte differentiation process triggered by inhibition of 
Wnt-signaling. To this end, we performed ChIP-Seq for H3K27me3 antibody (and H3 as a control) in 
mini-guts grown in stem cell media (WENRC) and in enterocyte differentiation media (ENRI) (heat 
maps in Supplemental figure 2). We also gauged the gene expression levels by performing GRO-Seq 
experiments for the mini-guts grown in the same culturing conditions. We used GRO-Seq to capture 
nascent unspliced RNA production disclosing the real-time transcriptional status of any given locus 
thus allowing better comparison of the data to ChIP-Seq. We found 2610 differentially expressed genes 
when comparing mini-guts grown in WENRC and ENRI (Supplemental table I). Altogether 1185 genes 
were upregulated in mini-guts grown in WENRC and 1425 genes were upregulated when grown in 
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ENRI. When ChIP- and GRO-Seq data were combined we found that out of 2610 differentially 
expressed genes 90 were regulated by PRC2 (3.4 %). Gene expression heat map in figure 2A illustrates 
the genes differentially expressed in mature enterocytes and in crypt/ISC cells. Expression heat map in 
figure 2B depicts the expression for the 90 genes found to be regulated by PRC2. When composite 
enrichment profile of H3K27me3, across the TSS in genes that are silenced by PRC2 in crypts/ISCs, 
were constructed it became evident that in enterocytes these genes are demethylated and consequently 
activated (figure 2C). Figure 2D demonstrates the data for the reciprocally behaving genes i.e. genes 
active in ISCs and later silenced by PRC2 in mature enterocytes. Figure 2E further recapitulates the 
magnitude of genome-wide accumulation and erasure of H3K27me3 during the enterocyte 
differentiation and also shows that genes which are subject to highest resettling of H3K27me3 also 
show significant gene expression difference when measured by GRO-Seq. These results indicate that a 
subset of crypt and villus specific gene expression during the differentiation of the small intestinal 
epithelium is regulated by PRC2.  
 
Novel intestinal PRC2 targets in mouse display villus and crypt specific expression pattern also in 
human tissues in vivo. 
Next we surveyed whether crypt/villus gene expression pattern found in mouse mini-guts also exists in 
humans in vivo. Majority of the differentially expressed genes also show comparable expression 
gradient in crypt-villus axis in small intestine in vivo when they were searched in protein atlas database 
[23] whenever immunohistochemical staining of the given protein was available (Supplemental figure 
3A-B).  PRC2 was found to mark canonical intestinal stem cell gene LGR5 [24] and genes associated 
with stem cell functions e.g. ASCL2 [25], CD24a [26], Igfbp4 [27] and Tnfrsf19 [28] with H3K27me3 
mark in mature enterocytes. Also negative regulator of Wnt-signaling gene, Axin2 [29], was found to 
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be a PRC2 target in villi (figure 3A). Figures 3B&C show some PRC2 targets and IHC staining 
snapshots from Protein Atlas database [23] providing confirmation that they are differentially 
expressed along the crypt-villus axis also in vivo in humans. We also tested the expression of the PRC2 
targets silenced in mouse enterocytes by performing RT-qPCR from crude mechanically fractionated 
crypt+TA/ISC and villus compartments to show that crypt domain specific expression pattern is also 
taking place in vivo (figure 3D). All targets were enriched in crypt compartment in a statistically 
significant manner except Marcksl1 which has been shown to be expressed also in villous microfold-
like cells (M-like cells) [30]. Crude mechanical fractioning was not applicable for enriching PRC2 
targets silenced in crypts as we find that they were expressed in 1:1 villus:crypt –ratio, except Slc15a1 
(6:1) (data not shown). Apparently crude mechanical villus fractioning detach only loose villus tip 
epithelium while terminally differentiated enterocytes in TA-region remain attached, as evinced by 
only subtle enrichment of Alpi (4-fold).  
As PRC2 is known to preferably target genes having function in development and signaling, as seems 
to be the case also in the intestine (figure 3A), we believe that these novel PRC2 targets on crypt-villus 
axis are also imperative for intestinal homeostasis.  
 
PRC2 determines the ISCs fate to enterocytes 
In murine and human embryonic stem cells and cell types derived thereof, PRC2 targets developmental 
regulators that must be repressed to maintain cell identity [3, 31]. We therefore asked which kind of 
gene sets are silenced by PRC2 at both ends along the crypt-villus axis in the adult intestine. Analyses 
of the gene ontologies indicate that in crypt/ISC region PRC2 represses genes belonging to the 
functional categories quintessential to enterocyte functions such as transport of various small molecules 
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at the apical side of the cells and also genes positively contributing to cell killing. Of note, PRC2 seems 
to also regulate genes involved in actin mediated microvillus structures at the brush border (figure 4A). 
In the mature enterocytes, on the other hand, PRC2 represses genes participating in cell proliferation, 
differentiation, epithelium development and digestive tract morphogenesis. In addition, PRC2 is 
targeted to genes involved in cell adhesion, ontology closely linked to epithelium shedding in villus tip 
(figure 4B). Taken together, these gene ontology analyses indicate that PRC2 is significantly targeted 
to genes involved in variety of enterocyte specific molecular functions amid enterocyte differentiation.  
Next we aimed to identify transcription factor target motifs enriched amongst PRC2 
regulated genes. We found de novo motif with the best match to TCF3 binding site to be significantly 
enriched in PRC2 regulated genes (P<10
-12
) when they were queried against PRC2-independent and 
differentially expressed genes along the crypt-villus axis (figure 4C). In the context of embryonic stem 
cell maintenance and differentiation PRC2 is known to be preferably targeted to genes having CpG 
islands in their promoters [32]. We found that PRC2 inclines to target genes harboring CpG islands 
also along the crypt-villus axis since genes regulated independent of PRC2 have less CpG islands 
amongst them (figure 4D). For instance, 78% of the PRC2-dependent crypt and villus specific genes 
have a CpG island in their promoter whereas only 65% of the PRC2-independent crypt and villus 
specific genes have that. These analyses pertaining to PRC2 targets along the crypt-villus axis show 
that likewise in embryonic stem cell differentiation, PRC2 is preferably targeted to genes possessing 
CpG islands. Furthermore, homer de novo motif search data suggest that TCF3 transcription factor, as a 
known effector in Wnt/β-catenin signaling pathway [33] is possibly implicated in PRC2-dependent 
intestinal homeostasis.  
 
 




PRC2 targets in intestine are implicated in colorectal adenomas and cancers 
Next we sought to investigate how PRC2-regulated intestinal transcriptome is associated with 
colorectal neoplasias. The APC gene encodes an adenomatous polyposis coli tumor-suppressor protein, 
the germline mutation of which leads to familial adenomatous polyposis, an autosomal syndrome 
characterized by multiple colorectal lesions [34]. APC inactivation is also a common key early event in 
the development of sporadic colorectal cancers,[35] which is modelled with APC knockout mouse in 
which Wnt-signaling is perturbed [36]. When we analyzed the sets of effective PRC2 targets in crypts 
and mature enterocytes (figure 2B) separately in gene set enrichment analysis (MSigDB) [37] we found 
that both shared significant amount of genes with gene sets of ‘upregulated genes following APC loss 
in mouse’ (P<2.64e-12) and ‘downregulated genes following APC loss in mouse’ (p<6.14e-5), 
respectively (figure 5A). This finding suggests that consequent to APC loss and concomitant Wnt-
signaling disturbance, colon epithelium is adopting more crypt/ISC –like gene expression pattern in a 
PRC2-dependent manner. This prompted us to analyze whether effective PRC2 targets in crypt-villus 
axis are also differentially expressed in colon malignancies in human. We found that significant set of 
effective intestinal PRC2 targets along the crypt-villus axis (hypergeometric distribution p<0.01) are 
differentially expressed in colorectal adenomas and carcinomas. Figures 5B-E show the PRC2 target 
expression data with genes that have altered expression both in colorectal adenomas and cancers. Thus 
by comparing our PRC2 target data with the gene expression data suggest that PRC2 is enacting the 
aberrancies in Wnt-signaling, the hallmark in in colorectal cancers [38]. Moreover, our data suggest 
that PRC2 participate in a malignant process where, in terms of H3K27me3 signature, epithelium in 
colorectal adenomas and cancers is rendered towards less mature crypt-type epithelium at the expense 
of mature enterocytes. 




PRC2 is out-of-bounds expressed and its target genes are affected in intestine in gluten-induced 
crypt hyperplasia in celiac patients   
We screened the expression of PRC2 protein SUZ12 in TA-region in celiac patients on gluten-free diet 
and the same patients after twelve weeks on gluten-containing diet. Immunohistochemical stainings 
with antibody against PRC2 core member SUZ12 protein showed that PRC2 is off-limits expressed in 
celiac gut on gluten-containing diet (figure 6A-B). As a consequence, PRC2 target genes Scinderin and 
SPHK1 were found downregulated in villus rudiments when celiac disease patients were consuming 
gluten (figure 6C-D). These results suggest that increased proliferation [39] in hyperplastic crypt in 
celiac patients, ignited by dietary gluten, is accompanied with the significantly less restraint PRC2 
expressions and concomitant downregulation of its target genes in villus rudiments. We also monitored 
the bulk H3K27me3 signal in crypt-villus axis with immunohistochemistry and found uniform signal 
both in gluten-containing and gluten-free diets (data not shown). 
To conclude, we propose a model where H3K27me3 methyltransferase activity of PRC2 
in lower and middle crypt region, maintains the Wnt-signaling regulated homeostasis between 
crypt/ISC and villus/enterocyte compartments in healthy intestine (figure 7A). In crypt hyperplasia, e.g. 
dietary gluten-induced in celiac patients, PRC2 is expressed off-limits and this leads to persistent 
silencing of its target genes in villus rudiments (figure 7B). 
 
DISCUSSION 
Our results indicate that the function of PRC2 at TA-region in the intestinal crypt-villus axis is to 
selectively set an epigenomic identity by labelling genes with repressive H3K27me3 mark and 
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therefore enforce and maintain the dichotomy for crypt and villus identities governed by Wnt-signaling 
(figure 7A). We have identified 90 genes regulated by PRC2 along the crypt-villus axis and among 
these are genes with already established roles in intestinal homeostasis and ISC maintenance e.g. 
LGR5, ASCL2 and Axin2. Bearing in mind that PRC2 specifically regulates genes having a function in 
development and signaling it is plausible to assume that also most of the identified PRC2 targets along 
the crypt-villus axis are causative agents in differentiation rather than just a mere consequence of it. 
Therefore, our work provides a resource for further studies dealing with the purportedly imperative 
factors maintaining the intestinal homeostasis. Many of these genes have been shown to be important in 
differentiation in other tissues and we summarize some of the targets here as an example.  
Genes expressed in villi and repressed in crypt/ISCs by PRC2: i) HES2. Hes-proteins (Comprises 
1-7 in humans) are basic helix-loop-helix DNA binding repressor proteins which play an essential role 
in the development of many organs by maintaining progenitor cells and regulating cell fate decisions 
[40]. Hes-proteins are effectors of Notch signaling but surprisingly HES2 was the only member from 
Hes-family found to be vigorously responsive to Wnt-signaling in PRC2-dependent fashion. This is 
interesting since from the members of Hes-family, HES2 is the one whose function is least known. Our 
data suggest that it is involved in enterocyte differentiation, contrary to Hes1, 3 and 5, which are all 
involved in secretory cell formation in the intestine [41]. ii) MAF is a DNA binding leucine zipper 
transcription factor involved in chondrocyte [42] and pancreatic beta cell differentiation [43]. Our data 
suggest that as a PRC2 target on crypt-villus axis it will also probably have a role in intestinal epithelial 
cell differentiation. iii) Scinderin was found downregulated in celiac patients’ on gluten-containing 
diet. Scinderin is a Ca
2+
 -dependent actin filament severing, end capping and nucleating protein 
involved in differentiation of megakaryoblasts,[44] osteoclasts [45] and chondrocytes [46] but the role 
in Wnt-mediated enterocyte differentiation is unknown.  
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Genes expressed in Crypt/ISCs and repressed in villi by PRC2: i) MNX1 is a homeobox 
transcription factor and mutations in this gene are linked to sacral agenesis and currarino syndrome, the 
latter having malformation mainly in anorectal region but sometimes duodenal atresias are present [47]. 
Mnx1 is involved in pancreatic development but early work with Mnx1-/- mice discovered abnormal 
growth in duodenum as well [48]. Our work suggests that in the small bowel MNX1 is a PRC2 target 
and solely expressed in duodenal crypts and probably have a role in maintaining the crypt-villus 
homeostasis. ii) The transcriptional repressor ZFP503 (Znf503 in human) plays a role in mammary 
gland homeostasis by promoting mammary epithelial cell proliferation [49]. Intestinal crypt restricted 
expression of ZFP503 by PRC2 suggests similar role in the intestinal homeostasis. iii) ETV4 is 
overexpressed in colorectal carcinomas and it has been shown to exert its pro-invasive and -metastatic 
functions through epithelial to mesenchymal transition and matrix metalloproteinase associated 
processes [50]. Our data showing that developmental regulator PRC2 silences ETV4 in villi 
accentuates the crucial role of PRC2 regulating genes involved in development and in this case the 
maintenance of gut homeostasis.  
PRC2 target genes along the crypt-villus axis were shown to have more CpG islands in 
their promoters which is a very typical tendency for PRC2 targets [51]. When effective PRC2 targets 
were queried against differentially expressed non-PRC2 targets genes along the crypt-villus axis, we 
found de novo motif with the highest match to Tcf3 transcription factor to be enriched.  Indeed, 
stimulation of the canonical Wnt-signaling pathway causes β-catenin to translocate to the nucleus and 
interact with Tcf/lef proteins to activate target genes [33]. It has been shown in mouse ES cells that 
nearly half of the genes bound by Tcf3 are also co-occupied by PRCs [52].  Our work suggest that in 
the intestine PRC2 is specifically involved in regulation of Tcf3 target genes in Wnt-signaling pathway.  
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It has been previously hypothesized that PRC-mediated gene repression might play a role 
in the pathogenesis of colorectal cancer [53]. This hypothesis has been set forth by the findings that 
PRC2 proteins interact with DNA methyltransferases [54] and that many genes that are frequently 
DNA hypermethylated in colorectal cancers are polycomb group target genes in human embryonic 
stem cells and fibroblasts [55] and in Caco-2 cancer cells [56]. Our genome-wide effective intestinal 
PRC2 target list assessed by H3K27me3-ChIP-Seq and Gro-Seq with non-differentiated and 
differentiated organoids derived from mouse duodenum now suggest that epithelium in adenomas and 
colorectal carcinomas adopt more crypt-like developmental status with respect to PRC2 imposed 
H3K27me3 signature. We also show that in celiac disease patients on gluten-containing diet causing 
crypt-hyperplasia is accompanied with the out-of-bounds PRC2 activity and consequent 
downregulation of its target genes in villi. In fact, the expression of PRC2 targets expressed in crypts 
(e.g. LGR5) might be also perturbed in celiac disease, as it has been shown before that number of 
immature proliferating TA progenitor cells expressing low levels of LGR5 were significantly increased 
in acute celiac disease [57].  
 
CONCLUSION 
Taken together, we have identified a PRC2 specified transcriptome, which forms an essential element 
in healthy gut homeostasis and aberrant PRC2 activity seems to be a common denominator in 
alimentary tracts diseases associated with epithelial cell hyperplasia e.g. in celiac disease (Figure 7B) 
or neoplasia in malignancies. Canonical intestinal stem cell effectors (e.g. Lgr5 and Ascl2) were found 
to be targets for developmental regulator PRC2, and thus identified novel PRC2 targets are also 
purportedly bona fide regulators of intestinal stem cell self-renewal and differentiation. Inhibition of 
methyltransferase activity of EZH2 component in PRC2 has emerged as a potential target for 
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development of novel therapeutic strategies in cancers. However, our data raises concerns for its 
feasibility in colorectal cancers as adverse pro-oncogenic effects might arise due to the pro-stemness 
and pro-differentiation functions of PRC2 in intestine. 
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Figure 1. PRC2 is expressed in crypt/ISCs-TA region and regulates enterocyte differentiation in vitro. 
(A) Quantitative reverse transcription PCR (qRT-PCR) showing the expression (mean and SD, n=3) of 
intestinal cell type markers in T84 cells grown in matrigel and treated with 5µM of EZH2 inhibitor or 
DMSO (vehicle). Bars represent the expression change after 6 days of EZH2 inhibition relative to 
DMSO treated cells. (LGR5, ISCs; ALPI, enterocytes; LYZ, paneth cells; CHGA, secretory cells; 
MUC2, goblet cells). Right, Western blotting of H3K27me3 and H3 (loading control) showing the 
decrease of bulk H3K27me3 level in cells treated with EZH2 inhibitor.  (B) qRT-PCR (mean and SD, 
n=3), as in A, for mouse mini-gut organoid cultures grown in stem cell media (WENRCV) and treated 
with 5µM of EZH2 inhibitor or DMSO. Significant p-values in t-tests are shown in A and B. (C) qRT-
PCR measurements of PRC2 members and GATA4 (control) in mouse mini-gut cultures grown in stem 
cell media (WENRC) and enterocyte differentiation media (ENRI). (D) qRT-PCR (mean and SD, n=3) 
from mechanically separated crypt (LGR5-marker) and villus (ALPI-marker) epithelium from mouse. 
Bars represent expression of PRC2 members SUZ12 and EZH2 in crypt/ISCs-TA region relative to 
villi. 
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Figure 2. PRC2 defines crypt and villus domains by marking genes with repressive H3K27me3. (A) 
Gene expression heat maps showing genes upregulated in mature enterocytes (magenta) and in 
intestinal stem cells (ISC)/crypt cells (green) studied by global run-on-sequencing (GRO-Seq) from 
mouse intestinal mini-gut organoids grown in enterocyte differentiation (ENRI) and stem cell media 
(WENRC) (two mice analyzed in batch as biological replicates; see methods). (B) Heat maps depicting 
subset of genes regulated by PRC2 (screened by H3K27me3 ChIP-Seq) on crypt-villus axis. (C) 
Composite enrichment profile of H3K27me3 at found PRC2 target genes that are silenced in 
crypts/ISCs (green) and later activated in enterocytes (magenta). (D) Composite enrichment profile of 
H3K27me3 at genes which are expressed in crypts/ISCs (green) and later silenced by PRC2 in 
enterocytes (magenta). Plots in C and D show average fold-enrichment (normalized signal from 
H3K27me3-ChIP-Seq versus whole genomic DNA). (E) Scatter blot demonstrating the genome-wide 
change in H3K27me3 occupancy during the differentiation of crypt/ISCs to mature enterocytes. Blue 
dots represents all normalized differential H3K27me3 ChIP-Seq peaks near protein coding genes of the 
mouse genome. Only the highest scoring peak per gene is shown. Red colored triangles denote the 
genes having significant gene expression difference measured by GRO-Seq and arrows quantitatively 
illustrate the gene expression difference in enterocytes relative to crypts/ISCs (up=activation, 
down=repression). Only the highest scoring peak per gene is shown. X-axis: H3K27me3 ChIP-Seq 
normalized tag count (log2) in organoids grown in WENRC i.e. crypt/ISCs and Y-axis: H3K27me3 
ChIP-Seq normalized tag count (log2) in organoids grown in ENRI i.e. mature enterocytes. 
Figure 3. PRC2 regulates the intestinal stem cell niche. (A) Above, H3K27me3 occupancy at canonical 
intestinal stem cell marker genes and wnt-signaling regulators in enterocytes (magenta) and in 
crypt/ISCs (green) (Y-axis: normalized tag count). Below, pre-mRNA expressions from corresponding 
genes are shown in enterocytes and in crypt/ISCs (Y-axis: normalized tag count). (B) Data (as in A) for 
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some of the novel PRC2 targets specifically repressed in crypt/ISCs. Immunohistochemical staining for 
the corresponding genes (obtained from Protein Atlas –database, www.proteinatlas.org) suggest that 
the expression gradient maintained by PRC2 is also occurring in humans in vivo. (C) Data (as in A and 
B) for the selected PRC2 targets in mature enterocytes. Both ChIP- and GRO-Seq data are shown as 
USCS genome browser snapshots aligned in corresponding genes (in A, B and C). (D) qRT-PCR data 
from crude mechanically isolated mouse crypt and villus fractions (mean and SD, n=3) for the PRC2 
targets silenced in enterocytes.   
Figure 4. PRC2 target genes are involved in intestinal homeostasis and enterocyte differentiation. (A) -
log P-values for the enrichment of GO & pathway-categories in the set of genes that are silenced by 
PRC2 in crypts/ISCs. (B) –log P-values for the enrichment of GO-categories in the set of genes that are 
silenced by PRC2 in mature enterocytes. (C) Best (p- and match-value combined) enriched de novo 
transcription target motif within PRC2-dependent crypt and villus specific genes when PRC2-
independent crypt and villus specific genes were used as a background. (D) The portion of genes with 
zero, one or two and more CpG islands in mouse genome in general (white bar) and crypt and villus 
specific genes not regulated by PRC2 (gray bar) and crypt and villus specific genes regulated by PRC2 
(black bar). 
Figure 5. Gene expression analyses suggest that aberrant stemness fostering PRC2 activity is 
implicated in adenomas and colorectal cancers. (A) Molecular Signatures Database (MSigDB) analyses 
with effective PRC2 targets in crypts/ISCs and mature enterocytes. P-values show the significance of 
the amount of shared genes between indicated queried and repository data sets. (B&C) Box plot charts 
of intestinal PRC2 targets and their significantly altered gene expression levels in adenomas. 
Microarray data is obtained from Gene Expression Omnibus (GEO) GDS2947[58] data set. Black lines 
indicate the median expression in 32 patients and upper and lower edges of the boxes mark the 







 quartiles. Tukey whiskers depict the lowest and highest data points within 1.5 
interquartile range. Gene expressions from colorectal adenomas (pink) and normal mucosas (green) 
from 32 patients are shown on log scale. (D&E) The expression of the same genes as above, obtained 
from GDS4382[59], in colorectal tumor (magenta) and adjacent non-cancerous tissues (green) from 17 
patients.  
Figure 6. PRC2 is out-of-bounds expressed and its enterocytic target genes are repressed in celiac 
patients on gluten-containing diet. (A) Representative immunohistochemical staining with PRC2 core 
member SUZ12 on duodenal biopsy sections obtained from celiac patient on gluten-free-diet (GFD) 
and from the same patient after 12 weeks on gluten containing-diet. (B) Line chart illustrates the 
quantitated SUZ12 immunohistochemical staining data from six patients on GFD and after gluten 
containing-diet. Dots represent mean and above is shown the p-value for t-test. (C) Representative 
immunohistochemical stainings for PRC2 targets Scinderin and (D) Sphk1 in celiac patients on GFD 
and on gluten-containing diet showing decrease in their expression upon gluten induced crypt 
hyperplasia  
Figure 7. Proposed model for the PRC2 function in maintaining the intestinal homeostasis and 
aberrancies therein in crypt hyperplasia. (A) At TA-region in the healthy intestine PRC2 (composed of 
core members SUZ12, EZH2 and EED proteins) impose crypt- and villus specific H3K27me3 
signatures and set the dichotomy for these two compartments. Solid line arrows illustrate how PRC2 
reigned transcriptional regulation takes place in lower and middle crypt region and dashed arrow 
indicate that repressive H3K27me3 is passively maintained in crypt genes once enterocytes have 
reached the terminal differentiation compartment in the upper crypt and migrate further to the villus.   
(B) In diseases inflicting crypt hyperplasia (e.g. celiac disease) PRC2 is expressed off-limits and 
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consequently its target genes in villi are less expressed possibly because they still retain some 
H3K27me3 modification. 
 
Supplemental figure 1. Optimizing mouse mini-gut culturing conditions to mimic intestinal crypt-
villus-axis. (A) qRT-PCR showing the expression (mean ± SD) of intestinal cell type markers relative 
to GAPDH in mouse mini-gut organoids grown in matrigel and basal culturing media (BCM, see 
methods) supplemented with W = Wnt3a, E = Egf, N = Noggin, R = R-Spondin, C = CHIR99021, V = 
Valproic acid, I = IWP2, D = DAPT.  (B) Relative expression of intestinal cell type markers (mean ± 
SD), measured by qRT-PCR, for chosen culturing conditions WENRC and ENRI for Crypt+ISC and 
enterocyte, respectively. Bars indicate the expression of genes in ENRI/enterocyte conditions relative 
to WENRC/Crypt+ISC conditions. (C) Representative microscopic pictures of organoids grown in 
WENRC and ENRI culturing conditions.           
 
Supplemental figure 2.  Heat maps of histone modification H3K27me3 signal (A) and histone 3 as a 
control (B) within +-10 kb of all transcriptional start sites (TSSs) in mouse genome in mini-guts grown 
in WENRC and ENRI media. Above the heat maps composite enrichment profiles of H3K27me3 
occupancy across the TSSs are shown (Y-axis, fold enrichment of H3K27me3).   
 
Supplemental figure 3. Example of genes differentially expressed in mini-guts and displaying also 
crypt and villus specific expression pattern in human in vivo when queried from Protein Atlas database 
(www.proteinatlas.org). (A) Showing data for the genes expressed in villus and (B) for the genes 
expressed in crypts. Above each IHC stainings (obtained from Protein Atlas database) corresponding 
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pre-mRNA expression detected in Gro-Seq from the given locus are shown as USCS genome browser 





Legend for Graphical Abstract. Schematic representation of the role of Polycomb Repressive 
Complex 2 (PRC2) on enacting the Wnt/β-catenin signaling and regulating the homeostasis of 
intestinal stem cell self-renewal and differentiation. At transit amplifying (TA) region PRC2 selectively 
set an epigenomic identity by labelling genes with repressive H3K27me3 mark and therefore enforce 
and maintain the dichotomy for crypt and villus identities. This manuscript suggest that PRC2 
contributes to the stemness instigation process in epithelial hyperplasia in celiac disease and in 
neoplasia in colorectal carcinoma. Schematic scatter blot on the right demonstrates the genome-wide 
change in H3K27me3 occupancy during the differentiation of crypt/Intestinal stem cells to mature 
enterocytes. Blue dots represents all normalized differential H3K27me3 ChIP-Seq peaks near protein 
coding genes of the mouse genome (above genes silenced in crypts and below genes silenced in villi). 
Red colored triangles denote the genes having significant gene expression difference measured by 
GRO-Seq and arrows quantitatively illustrate the gene expression difference in enterocytes relative to 
crypts/ISCs (up=activation, down=repression).  
 
 








Figure 1. PRC2 is expressed in crypt/ISCs-TA region and regulates enterocyte differentiation in vitro.  
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Figure 2. PRC2 defines crypt and villus domains by marking genes with repressive H3K27me3.  
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Figure 3. PRC2 regulates the intestinal stem cell niche.  
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Figure 4. PRC2 target genes are involved in intestinal homeostasis and enterocyte differentiation.  
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Figure 5. Gene expression analyses suggest that aberrant stemness fostering PRC2 activity is implicated in 
adenomas and colorectal cancers.  
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Figure 6. PRC2 is out-of-bounds expressed and its enterocytic target genes are repressed in celiac patients 
on gluten-containing diet.  
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Figure 7. Proposed model for the PRC2 function in maintaining the intestinal homeostasis and aberrancies 
therein in crypt hyperplasia.  
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SUPPLEMENTAL MATERIALS AND METHODS  
 
GRO-Seq data analysis 
The quality of reads was confirmed using FastQC tool [1] and poor quality reads were removed 
(minimum 97% of bp over phred quality cutoff 10) using the FastX toolkit 
(http://hannonlab.cshl.edu/fastx_toolkit/). The filtered data was mapped using Bowtie [2] allowing up to 
two mismatches and reporting only one alignment for each read. Data analysis was performed using 
HOMER 4.3 [3].  
HOMER programs “analyseRepeats.pl” and “getDiffExpression.pl” with the parameter “-batch” were 
used to get a list of differentially transcribed genes in the WENRC and ENRI samples while treating 
them as biological replicates utilizing edgeR [4]. Normalized values were used, denoted as RPKM (= 
reads per kilobase per million mapped reads = [# of mapped reads]/[length of transcript in kilo 
base]/[million mapped reads]). Differential transcripts were selected when RPKM > 0.5 in any sample, 
log2 fold change ≥ ±1 between WENRC and ENRI and P < 0.05. 
 
ChIP-Seq data analysis 
Quality control analysis was produced by FastQC. Quality metrics were observed and all libraries were 
of high quality. No poor quality sequences, sequence duplication, overrepresented sequences or adapter 
content was observed. Libraries of WENRC and ENRI pools were aligned to Mus musculus reference 
genome assembly (NCBI37/mm9) with Bowtie2 [5]. To identify H3K27me3 histone modification in the 
WENRC and ENRI sets the HOMER program suite was utilized [3]. G+C-content was measured with 
HOMER using the command “makeTagDirectory” with “-checkGC” option. This provides GC% for 
normalized genomic and tag fractions and can be plotted to visualize the possible G+C-content bias 
between the genome and sample. No G+C-content bias was observed in the ChIP-Seq samples 
(Supplemental materials and methods Figure 1). Average sample fragment GC% was within 1.6% of 
average expected GC% in all samples and input (Supplemental materials and methods table I).  
 




Supplemental materials and methods Figure 1. G+C-content analysis 
 
Supplemental materials and methods table I: GC content in sequenced samples 
Sample Average Fragment GC% Average Expected GC% 
WENRC input 40.96% 41.39% 
WENRC 42.82% 41.39% 
ENRI input 40.71% 41.40% 
ENRI 42.97% 41.39% 
 
Peaks were called with “findPeaks” with parameter “-histone”. This makes the program to identify 500 
bp peaks that are significantly enriched compared to input control (4 fold). Variable length peaks are 
produced by stitching called peaks together if they are within 1000 bp of each other.  
Additionally a second round of peak calling for detection of broader peaks was performed with 
“findPeaks” with parameters “-size 1000” and “-minDist 10000”. Identification of peaks starting with 
size 1000 bp and stitching range of 10 000 bp allowed the identification of larger histone modification 
areas. 
Regions identified by these approaches were merged. Differentially bound regions were identified with 
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ENRI sample background and vice versa. Two fold (log2) differences between WENRC and ENRI 
samples were considered significant when P < 10-12 and. This resulted in two list of genes enriched for 
H3K27me3 in WENRC or ENRI samples. 
 
Identification of intestinal PRC2 targets 
Differentially transcribed genes were identified with GRO-Seq and PRC2 targets by H3K27me3 ChIP-
Seq as explained above. Altogether, 52 protein coding genes were found repressed by PRC2 in 
crypts/ISCs (WENRC) and upregulated in enterocytes (ENRI) and 38 genes repressed by PRC2 in 
enterocytes (ENRI) and upregulated in crypts/ISCs (WENRC) (Figure 2B).    
 
Heatmaps 
Differentially expressed transcripts and differentially H3K27me3 modified  genes were hierarchically 
clustered with Cluster 3.0 [6] using average linkage and was visualized in Java Treeview 1.1.6r4 [7]. 
Read coverage visualizations of H3K27me3 in WENRC and ENRI pools were generated with the 
deepTools program package by bamCoverage, computeMatrix and heatmapper [8]. File conversion to 
BAM format was performed using SAMtools [9]. Bigwig files were generated by bamCoverage with 
binSize 10 and normalized to 1 x sequencing depth using fragment size available from HOMER’s Tag 
directory analysis. Matrixfiles needed for generating the heatmaps were done with the program 
computeMatrix using TSS as a reference-point with range of ± 10 000 bases. Then the program 
heatmapper was utilized to retrieve the visualized representation of the H3K27me3 data as a heatmap 
with a histrogram.  
 
CpG islands 
All CpG island locations within the mm9 reference genome were downloaded from the UCSC Genome 
Bioinformatics Site’s Table Browser http://genome.ucsc.edu/cgi-bin/hgTables. CpG island intersections 
with exact H3K27me3 peaks or -15 kb from TSS of differentially transcribed genes were analyzed with 
intersectBed from the bedtools suite [10]. 




Homer de novo motif analyses for intestinal PRC2 target genes 
HOMER was utilized to search for enriched motifs with lengths of 6 to 16 bases spanning the TSS from 
-1000 to +500 bases in H3K27me3 target genes using the differentially expressed, non-PRC2 targets 
genes as a background. 
 
Intestinal PRC2 targets in colorectal cancers and adenomas  
Microarray data for colorectal cancer tumors (GDS4382) [11] and colorectal adenoma formation 
(GDS2947) [12] were downloaded from http://www.ncbi.nlm.nih.gov/geo/. Two tailed paired Student’s 
t-test with adjusted P < 10-3 (Benjamini & Hochberg corrected) was used to determine differently 
expressed genes in the microarray sets. First, list of genes (n=38) expressed in crypt/ISCs and silenced 
by PRC2 in enterocytes were compared to genes upregulated in colorectal cancer tumors and adenomas 
compared to adjacent healthy foci. In these comparisons, from the 38 queried genes, 17 were found 
upregulated in colon cancers (hypergeometric test: P < 2.76e-05) and 18 in adenomas (hypergeometric 
test: P < 5.44e-04) and genes upregulated in both diseases (n=14) are shown in Figures 5B and 5D. 
Second, list of genes (n=52) expressed in enterocytes and silenced by PRC2 in crypts/ISCs were 
compared to genes downregulated in colorectal cancer tumors and adenomas compared to adjacent 
healthy foci. In these comparisons, from the 52 queried genes, 15 were found downregulated in colon 
cancers (hypergeometric test: P < 5.15e-03) and 21 in adenomas (hypergeometric test: P < 3.17e-03) 
and genes upregulated in both diseases (n=12) are shown in figures 5C and 5E.  
 
Gene ontology and pathway analyses 
Over-represented gene ontologies and pathways amongst PRC2 targets in crypts/ISCs and enterocytes 




Page 66 of 69
5 
 
Supplemental materials and methods Table I. List of qRT-PCR oligos used in this study  
Oligonucleotide Species Sequence (5' to 3')  
Gapdh_fwd Hs TCCATGACAACTTTGGTATCGTGG 
Gapdh_rev Hs GACGCCTGCTTCACCACCTTCT 
Lgr5_fwd Hs GAAGATTTCCTGCTTGACTTTG  
Lgr5_rev Hs GGATCTGAAAACTGTTGAAGTCAC 
Alpi_fwd Hs CCTTTGGTGGCTACACCTTGC  
Alpi_rev Hs CGCCTGCTGCTGGTAATCG 
Lyz_fwd Hs GAGAGTGGTTACAACACACGAGC  
Lyz_rev Hs ATCACGGACAACCCTCTTTGC 
Chga_fwd Hs CTCCAGGTCCGAGGCTACC  
Chga_rev Hs GTAGTGCCTGCAGCTGGTGG 
Muc2_fwd Hs CTGTAAGAAGTGTGAACAGACGC  
Muc2_rev Hs AATGCTGGCATCAAAGTTGG 
Gapdh_fwd Mm TGTGTCCGTCGTGGATCTGA  
Gapdh_rev Mm CCTGCTTCACCACCTTCTTGA 
Lgr5_fwd Mm GACAATGCTCTCACAGACGTCC  
Lgr5_rev Mm CAGGGAGTGGATTCTATTATTATGGAG 
Alpi_fwd Mm CCACAAGGCTTCTACCTCTTTGTAG  
Alpi_rev Mm CGGGTGTAGGATTTGTCATCTAGG 
Lyz_fwd Mm GGAATGGATGGCTACCGTGG  
Lyz_rev Mm CACAGGCATTCTTAGATCTTGGG 
Chga_fwd Mm GTGCGTCCTGGAAGTCATCTCC  
Chga_rev Mm GAGAGCCAGGTCTTGAAGTTCC 
Muc2_fwd Mm GGAACCGGGAAGATGCACTC  
Muc2_rev Mm GTCAGCAGCCTCTCACATTCG 
Suz12_fwd Mm GATGAGAAAGATCCAGAATGGC  
Suz12_rev Mm ATAATTTTCTACAAACAGCATACAGGC 
Ezh2_fwd Mm GTCTGATGTGGCAGGCTGG  
Ezh2_rev Mm GCCCTTTCGGGTTGCATC 
Gata4_fwd Mm GAGCCTGTATGTAATGCCTGCG  
Gata4_rev Mm GGAGGGTCTCACCAGCAGG 
Zfp503_fwd Mm GCACCCAGAGTATTTGCAACCC 
Zfp503_rev Mm CCCTATCTGCGAACATGTTTGAGC 
Marcksl1_fwd Mm GAGGAGGCAGCGGGCGC 
Marcksl1_rev Mm GGCTCGATGGCATCACCAGTAG 
Cdk6_fwd Mm CCTGGAGACCTTCGAGCAC 
Cdk6_rev Mm GTGAGAATGAAGAAAGTCCAGACC 
Etv4_fwd Mm GCGGATACTTGGACCAGCGAG 
Etv4_rev Mm GTCTCTTGGAAGTGACTGAGGTCC 
Scin_fwd Mm CAGCTGGGAGAGCTTCAACAAG 
Scin_rev Mm GACGCTCATATTTGTTGCAGGAG 
Arg2_fwd Mm CAACCAGGAACTGGCTGAAG 
Arg2_rev Mm GGCGTGACCGATAATGGTAC 
Sphk1_fwd Mm CCTGGAGGAGGCAGAGATAACC 
Sphk1_rev Mm CCAGTCTGGCCGTTCCATTAG 
Slc15a1_fwd Mm GATCGCAGACTCGTGGCTGG 
Page 67 of 69
6 
 
Slc15a1_rev Mm GGAAGGCTGTCAGGACTGCC 
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